# Bluejay Diagnostics, Inc.: Form SCHEDULE 13D, filed Mar 11, 2026

- Company: [Bluejay Diagnostics, Inc.](/companies/bjdx.md) (CIK 1704287)
- Form: SCHEDULE 13D
- Filed: 2026-03-11
- Accepted by EDGAR: Mar 11, 2026, 08:12 ET
- Period: not reported
- Accession: 0001213900-26-025962
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1704287/000121390026025962/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1704287/000121390026025962/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1704287/000121390026025962/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-025962. Last ingested by Listed: Nov 4, 2026, 07:12 ET. No prices; not investment advice.